Logo image of LASE

LASER PHOTONICS CORP (LASE) Stock Fundamental Analysis

NASDAQ:LASE - Nasdaq - US51807Q1004 - Common Stock - Currency: USD

3.45  -0.21 (-5.74%)

After market: 3.4996 +0.05 (+1.44%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LASE. LASE was compared to 129 industry peers in the Machinery industry. No worries on liquidiy or solvency for LASE as it has an excellent financial health rating, but there are worries on the profitability. LASE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

LASE had negative earnings in the past year.
In the past year LASE has reported a negative cash flow from operations.
LASE Yearly Net Income VS EBIT VS OCF VS FCFLASE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -2M -4M

1.2 Ratios

LASE's Return On Assets of -103.45% is on the low side compared to the rest of the industry. LASE is outperformed by 94.40% of its industry peers.
Looking at the Return On Equity, with a value of -113.41%, LASE is doing worse than 88.80% of the companies in the same industry.
Industry RankSector Rank
ROA -103.45%
ROE -113.41%
ROIC N/A
ROA(3y)-7.15%
ROA(5y)N/A
ROE(3y)-7.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LASE Yearly ROA, ROE, ROICLASE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 10 -10 -20

1.3 Margins

LASE has a better Gross Margin (45.55%) than 84.80% of its industry peers.
In the last couple of years the Gross Margin of LASE has grown nicely.
The Profit Margin and Operating Margin are not available for LASE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.55%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.39%
GM growth 5YN/A
LASE Yearly Profit, Operating, Gross MarginsLASE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 50 -50

8

2. Health

2.1 Basic Checks

LASE does not have a ROIC to compare to the WACC, probably because it is not profitable.
LASE has more shares outstanding than it did 1 year ago.
LASE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LASE Yearly Shares OutstandingLASE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M 8M
LASE Yearly Total Debt VS Total AssetsLASE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

LASE has an Altman-Z score of 28.87. This indicates that LASE is financially healthy and has little risk of bankruptcy at the moment.
LASE has a Altman-Z score of 28.87. This is amongst the best in the industry. LASE outperforms 99.20% of its industry peers.
LASE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 28.87
ROIC/WACCN/A
WACC11.04%
LASE Yearly LT Debt VS Equity VS FCFLASE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 5.38 indicates that LASE has no problem at all paying its short term obligations.
LASE's Current ratio of 5.38 is amongst the best of the industry. LASE outperforms 92.00% of its industry peers.
LASE has a Quick Ratio of 3.31. This indicates that LASE is financially healthy and has no problem in meeting its short term obligations.
LASE has a Quick ratio of 3.31. This is amongst the best in the industry. LASE outperforms 90.40% of its industry peers.
Industry RankSector Rank
Current Ratio 5.38
Quick Ratio 3.31
LASE Yearly Current Assets VS Current LiabilitesLASE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 5M 10M 15M

2

3. Growth

3.1 Past

The earnings per share for LASE have decreased strongly by -88.45% in the last year.
The Revenue for LASE has decreased by -44.07% in the past year. This is quite bad
Measured over the past years, LASE shows a very strong growth in Revenue. The Revenue has been growing by 22.37% on average per year.
EPS 1Y (TTM)-88.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.44%
Revenue 1Y (TTM)-44.07%
Revenue growth 3Y22.37%
Revenue growth 5YN/A
Sales Q2Q%-42.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LASE Yearly Revenue VS EstimatesLASE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 1M 2M 3M 4M
LASE Yearly EPS VS EstimatesLASE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

LASE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LASE Price Earnings VS Forward Price EarningsLASE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LASE Per share dataLASE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

LASE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LASER PHOTONICS CORP

NASDAQ:LASE (2/21/2025, 8:00:02 PM)

After market: 3.4996 +0.05 (+1.44%)

3.45

-0.21 (-5.74%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-11 2023-05-11/bmo
Earnings (Next)N/A N/A
Inst Owners3.18%
Inst Owner Change-94.52%
Ins Owners2.85%
Ins Owner Change0%
Market Cap47.71M
AnalystsN/A
Price TargetN/A
Short Float %8.51%
Short Ratio1.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 18.51
P/FCF N/A
P/OCF N/A
P/B 4.93
P/tB 8.43
EV/EBITDA N/A
EPS(TTM)-1.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.61
OCFYN/A
SpS0.19
BVpS0.7
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -103.45%
ROE -113.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.55%
FCFM N/A
ROA(3y)-7.15%
ROA(5y)N/A
ROE(3y)-7.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.39%
GM growth 5YN/A
F-Score2
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 52.26%
Cap/Sales 17.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.38
Quick Ratio 3.31
Altman-Z 28.87
F-Score2
WACC11.04%
ROIC/WACCN/A
Cap/Depr(3y)54.81%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.27%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.44%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-44.07%
Revenue growth 3Y22.37%
Revenue growth 5YN/A
Sales Q2Q%-42.18%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1058.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-827.65%
OCF growth 3YN/A
OCF growth 5YN/A